Celvive is a Rutgers University start up company active in the fields of cell processing, cell delivery and clinical cell therapy for regenerative medicine applications. Celvive has developed the StemCure™ cell isolation and delivery system, which has been tested and is being prepared for a regulatory submission to the FDA. This new regenerative medicine approach is being utilized for treating patients with their own adult stem cells to enhance regeneration of spinal nerves.